For the Media
Dr. Laura Panattoni is a staff scientist in Fred Hutch's Public Health Sciences Division working with the Hutchinson Institute for Cancer Outcomes Research (HICOR). She has extensive experience in the field of health economics and expertise in both primary and cancer care delivery. Dr. Panattoni's provides scientific guidance to the HICOR Value in Cancer Care Initiative, a regional consortium of cancer care delivery organizations aiming to reduce unnecessary hospitalization and surveillance testing, and improve end of life care. Her current projects include profiling delivery organization performance and estimating the costs associated with potentially preventable emergency department utilization during cancer treatment.
Laura Panattoni - Brief Curriculum Vitae
Appointments, affiliations and researcher interests
Hutchinson Institute for Cancer Outcomes Research (HICOR) is a research institute at Fred Hutch whose mission is to improve cancer prevention, detection and treatment in ways that will reduce the economic and human burden of cancer—ultimately leading to better outcomes for patients.
Public Health Sciences Division
Using large populations as our laboratory, our researchers look for links between cancer and its possible triggers, from diet and lifestyle to environmental and genetic factors.
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.